MEDIUM

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

Medium Nutrient agar base with ferric citrate

Bile esculin agar (BEA)

Bile esculin agar (BEA) Nutrient agar base with

ferric citrate

Hydrolysis of esculin by group D streptococci imparts a ? color to medium; sodium desoxycholate inhibits many bacteria

brown

Hydrolysis of esculin by ? imparts a brown color to medium; sodium desoxycholate inhibits many bacteria

group D streptococci

Differential isolation and presumptive identificationof group D streptococci and enterococci

Bile esculin agar (BEA)

Bile esculin agar (BEA) Differential isolation and presumptive identification of ?

group D streptococci and enterococci

Selective and differential for cultivation of vancomycin-resistant enterococci from clinical and surveillance specimens

Bile esculin azide agar with Vancomycin

Bile esculin azide agar with Vancomycin Contains azide to inhibit ?

gram-negative bacteria

Bile esculin azide agar with Vancomycin Contains azide to inhibit gram-negative bacteria, vancomycin to select for resistant ?

gram-positive bacteria,

Cultivation of nonfastidious microorganisms,determination of hemolytic reactions

Blood agar

Blood agar Cultivation of ? microorganisms,determination of hemolytic reactions

nonfastidious

Blood agar Components

Trypticase soy agar, Brucella agar, or beef heart infusion with 5% sheep blood

Isolation of Bordetella pertussis and Bordetella Parapertussis

Bordet-Gengou agar

Bordet-Gengou agar Isolation of

Bordetella pertussis and Bordetella Parapertussis

Cultivation of fastidious organisms

Brain heart infusion agar or Broth

Brain heart infusion agar or Broth Cultivation of ? organisms

fastidious

Enrichment for Legionella spp.Supports the growth of Francisella and Nocardia spp.

Buffered charcoal-yeast extract agar (BCYE)

Buffered charcoal-yeast extract agar (BCYE) Enrichment for ? Supports the growth of ? (2)

Legionella spp. Francisella and Nocardia spp.

supplemented with polymyxin B, vancomycin, and ansamycin, to inhibit gram-negative bacteria, gram-positive bacteria, and yeast, respectively

Buffered charcoal-yeast extract (BCYE) agar with antibiotics

Enrichment and selection for Legionella spp ONLY

Buffered charcoal-yeast extract (BCYE) agar with antibiotics

For recovery of B. Cepacia from cystic fibrosis patients

Burkholderia cepacia selective Agar

Burkholderia cepacia selective Agar For recovery of ? from cystic fibrosis patients

B. Cepacia

Burkholderia cepacia selective Agar For recovery of B. Cepacia from ? patients

cystic fibrosis

Selective for Campylobacter spp

Campy-blood agar

Campy-blood agar Selective for

Campylobacter spp

Thioglycollate broth supplemented with increased agar concentration and antibiotics

Campylobacter thioglycollate Broth

Selective holding medium for recovery of Campylobacter spp. Incubated at 4° C for cold enrichment

Campylobacter thioglycollate Broth

Improved growth of obligate, slow-growing; Anaerobes

CDC anaerobe 5% sheep blood agar

Selective medium for isolation of Campylobacter spp.

Cefoperazone, vancomycin,amphotericin (CVA) medium

Selective for Yersinia spp.; may be useful for isolation of Aeromonas spp.

Cefsulodin irgasannovobiocin (CIN) agar

Cefsulodin irgasannovobiocin (CIN) agar Selective for ?.; may be useful for isolation of Aeromonas spp.

Yersinia spp

Cefsulodin irgasannovobiocin (CIN) agar Selective for Yersinia spp.; may be useful for isolation of ?

Aeromonas spp.

Cultivation of fastidious microorganisms such asHaemophilus spp., Brucella spp. and pathogenic Neisseria spp

Chocolate agar

Chocolate agar Cultivation of ? microorganisms such asHaemophilus spp., Brucella spp. and pathogenic Neisseria spp

fastidious

Chocolate agar Cultivation of fastidious microorganisms such as ? (3)

Haemophilus spp., Brucella spp. and pathogenic Neisseria spp

are designed to optimize growth and differentiate a specific typeof organism. are routinely used in the identification of yeasts, methicillin-resistant Stapylococcus aureus (MRSA), and a variety of other organisms

Chromogenic media

Selective isolation of grampositive cocci

Columbia colistinnalidixic acid (CNA) agar

Columbia colistinnalidixic acid (CNA) agar Selective isolation of

grampositive cocci

Isolation of C. diphtheria

Cystine-tellurite blood agar

Cystine-tellurite blood agar Isolation of

Corynebacterium diphtheriae

Cystine-tellurite blood agar Infusion agar base with 5% sheep blood; reduction of potassium tellurite by Corynebacterium diphtheriae produces ?

black colonies

Isolation and differentiation of lactose-fermenting and non–lactose-fermenting enteric bacilli

Eosin methylene blue (EMB) agar (Levine) MacConkey agar

Selective (enrichment) liquid medium for enteric Pathogens

Gram negative broth (GN)

Differential, selective medium for the isolation and differentiation of Salmonella and Shigella spp.from other gram-negative enteric bacilli

Hektoen enteric (HE) agar

Hektoen enteric (HE) agar Differential, selective medium for the isolation and differentiation of ? (2) spp.from other gram-negative enteric bacilli

Salmonella and Shigella

Isolation and growth of Corynebacterium

Loeffler’s medium

Loeffler’s medium Isolation and growth of

Corynebacterium

Selective differentiation of staphylococci

Mannitol salt agar

Mannitol salt agar Selective differentiation of

staphylococci

Selective for Neisseria gonorrhoeae; also supports the growth of Ureaplasma urealyticum and some Mycoplasma spp

New York City (NYC) agar

Selective isolation of aerobic gram-positive cocci and bacilli and anaerobic gram-positive cocci and negative bacilli

Phenylethyl alcohol (PEA) Agar

Phenylethyl alcohol (PEA) Agar Selective isolation of

aerobic gram-positive cocci and bacilli and anaerobic gram-positive cocci and negative bacilli

Enrichment and selective medium for isolation of Bordetella pertussis

Regan Lowe

Regan Lowe Enrichment and selective medium for isolation of

Bordetella pertussis

Selective for Salmonella and some Shigella spp.

Salmonella-Shigella (SS) agar

Salmonella-Shigella (SS) agar Selective for ?

Salmonella and some Shigella spp.

Nonselective medium for the recovery of anaerobes and aerobes Selective for Campylobacter and Helicobacter spp.

Schaedler agar

Enrichment of isolation of Salmonella spp.

Selenite broth

Selective for Campylobacter spp.

Skirrow agar

Skirrow agar Selective for ?

Campylobacter spp.

Selective for Streptococcus pyogenes andStreptococcus agalactiae

Streptococcal selective agar (SSA)

Streptococcal selective agar (SSA) Selective for

Streptococcus pyogenes andStreptococcus agalactiae

Selective for Salmonella and Shigella spp. except S.typhi.

Tetrathionate broth

Selective for N. gonorrhoeae and N. meningitidis.Supports the growth of Francisella and Brucella Spp

Thayer-Martin agar (modified Thayer Martin)

Thayer-Martin agar (modified Thayer Martin) Selective for ? .Supports the growth of Francisella and Brucella Spp

N. gonorrhoeae and N. meningitidis

Thayer-Martin agar (modified Thayer Martin) Selective for N. gonorrhoeae and N. meningitidis. Supports the growth of ?

Francisella and Brucella Spp

Supports growth of anaerobes, aerobes, microaerophilic, and fastidious microorganisms

Thioglycollate broth

Thioglycollate broth Supports growth of (4) microorganisms

anaerobes, aerobes, microaerophilic, and fastidious

Selective and differential for Vibrio spp

Thiosulfate citrate-bile salts (TCBS) agar

Thiosulfate citrate-bile salts (TCBS) agar Selective and differential for

Vibrio spp

Selection and enrichment for Streptococcus agalactiae in female genital specimens

Todd-Hewitt broth supplemented with antibiotics (LIM)

an enrichment broth for streptococci, is supplemented with nalidixic acid and gentamicin or colistin for greater selectivity; thioglycollate and agar reduce redox potential

Todd-Hewitt

All-purpose enrichment broth that can support the growth of many fastidious and nonfastidious bacteria

Trypticase soy broth (TSB)

Enrichment broth used for subculturing various bacteria from primary agar plates

Trypticase soy broth (TSB)

Isolation and differentiation of Salmonella andShigella spp. from other gramnegative entericbacilli

Xylose lysine desoxycholate (XLD) agar

– both liquid and solid phase (usually in blood culture methods)

biphasic medium

PRIMARY &DIFFERENTIAL MEDIA OF CHOICE FOR FECAL RECOVERY OF FECAL PATHOGEN

MAC HE CAMPYLOBACTER CNA

For obligate intracellular parasites that require viable host cells for propagation

Cell culture

Most commonly used in diagnostic virology

Cell culture

Most clinically significant aerobic organisms are actually _________ anaerobic

FACULTATIVE

Aerobic: BACTERIAS

Pseudomonas, Neisseriaceae, Brucella, and Francisella

Environmental Requirements O2

Obligate aerobes

Environmental Requirements O2 growth but best at no O2.

Aerotolerant Aerobes

Environmental Requirements Both O2 and no O2

Facultative anaerobes

Environmental Requirements No O2

Obligate anaerobes

Environmental Requirements CO2

Capnophilic

Environmental Requirements Reduced O2 (20%) 5% to 6% O2

Microaerophlic/Microaerobic

tablet of _________ is dissolved by the moisture created within an airtight plastic bag and releases sufficient CO2 to support growth of the pathogen

sodium bicarbonate

_________ can also generate a CO2 concentration of approximately 3%

candle jar

candle jar can also generate a CO2 concentration of approximately %?

_________ : Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria gonorrhoeae

CAPNOPHILES

CAPNOPHILES :

Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria gonorrhoeae

Air = _________ and _________

= 21 % O2 % and 1 % CO2

Air

Incubator O2 is decreased to _________ when CO2 content of aerobic incubator is increased to _________

18%; 10%

- Most clinically relevant bacteria prefer a near neutral pH

Water is provided as a major constituent of both agar and broth media

Moisture

Temperature Growth Temp =

35 -37 %

Temperature = 35 -37 %

Growth Temp

100

Temperature Psychrophiles:

10-20oC

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前